In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SanBio Co. Ltd.

www.san-bio.com

Latest From SanBio Co. Ltd.

Dainippon Closing In On Cell Therapy Specialist Cynata

Australian venture with Phase II-ready cell therapy in sights of Sumitomo Dainippon as Japanese firm looks to build regenerative medicine interests and pipeline ahead of major expiry.

M & A Business Strategies

Dainippon’s Lead Boston Asset Hits Wall In Pancreatic Cancer

Dainippon Sumitomo suffers major Phase III setback for one of its key oncology prospects, and although the former Boston Biomedical asset will carry on in other planned indications, the Japanese firm may have to look for ways to fill the gap.

Clinical Trials Cancer

Surprising SanBio/Sumitomo Stroke Stumble Slams Stocks

Mesenchymal stem cell-based therapy's missed Phase IIb endpoint in stroke prompts both an assessment of future development plans and a precipitous fall in developers' stocks.

Japan Regenerative Medicine

Tech Transfer Roundup: How To Protect Downstream Rights

A review of tech transfer deals over 10 years shows that licensees often protect their value positions to limit royalties paid out to licensors. Meanwhile, licensors often protect their future rights with language recognizing that additional parties may be involved in producing a final product.

Deals Intellectual Property
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • SanBio Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • SanBio Co. Ltd.
  • Senior Management
  • Keita Mori, Co-CEO & Chmn.
    Bijan Nejadnik, MD, CMO
  • Contact Info
  • SanBio Co. Ltd.
    Phone: (3)-6264-3481
    8-1 Akashi-cho, Chuo-ku/ St. Luke Tower
    28F
    Tokyo, CA 104-0044
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register